Ballard Spahr assisted RhythMedix on the sale. Pharos Capital Group has acquired a majority stake in New Jersey-based RythMedix, a manufacturer and provider of remote cardiac...
You must be a Standard 1 Year member to access this content.
Ballard Spahr assisted 3Helix on the round. BASF and 3Helix Inc., a U.S.-based technology start-up, announced their innovation partnership on 3Helix’s proprietary CHP technology. The partnership...
You must be a Standard 1 Year member to access this content.
Ballard Spahr advised PA Natural Medicine LLC on the deal. Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF), a vertically-integrated cannabis multi-state operator (MSO), has closed, through a...
You must be a Standard 1 Year member to access this content.
